Interview with Steve Holtzclaw, CEO at U.S. Orthopaedic Partners

Steve Holtzclaw, MD, MBA, is the CEO of U.S. Orthopaedic Partners, a position he assumed on January 1, 2024. A seasoned professional, Dr. Holtzclaw brings a wealth of experience and expertise to his new role. He has showcased transformative leadership skills during his tenure as CEO at Alteon Health, one of the country’s largest physician-led acute care medical groups, and also as president of hospital-based services for TeamHealth. It was in this role that Dr. Holtzclaw led the expansion and progress of healthy business relationships, clinician relations, organizational development, financial solvency, and revenue generation.

With a background that began as an EMT/paramedic, Dr. Holtzclaw holds undergraduate degrees in business administration and biology. He earned his medical degree at the University of Maryland and completed his emergency medicine residency at Johns Hopkins University. He later returned to Johns Hopkins to serve as an instructor, nurturing future medical practitioners, and still returns there monthly as a practicing physician.

Connect with Steve and U.S. Orthopaedic Partners on LinkedIn.

Interview Questions:

News | On January 1, 2024, you were appointed CEO of U.S. Orthopaedic Partners. Please share your reasons for joining the company.

Introduction | Can you provide an introduction to U.S. Orthopaedic Partners and the services provided? Results.

Footprint | What is the footprint of U.S. Orthopaedic Partners? What differentiates U.S. Orthopaedic Partners from competitors?

Career | Your career included stints as CEO of Alteon Health and interim CEO at True Value Analytics. Please share some highlights from your career.

Acquisitions | U.S. Orthopaedic has been an active acquirer. Can you tell us about the recent acquisitions?

Priorities | What are your major priorities as CEO?

Private Equity | FFL Partners are experienced private equity investors in healthcare. Tell us about FFL Partners and their vision for the company.

Future | What is your vision for the company? The industry ( ie. ASCs).

Since its launch in 2020, U.S. Orthopaedic Partners has rapidly emerged as a leading provider of high-quality, value-based orthopaedic care across the Southeast. Supported by diversified orthopedic sub-specialties, ultramodern ambulatory surgery centers, fellowship training programs, and comprehensive suite of ancillary services—including advanced imaging, rehabilitation, pain management, urgent care, pharmacy and sports medicine—USOP is a comprehensive provider for patients seeking high quality, value-based care.